688073 Bide Pharmatech
- 49.28
- -2.02-3.94%
Bide Pharmatech News
Haitong Securities Co., Ltd. inspection opinions on the departure of core technicians of Shanghai Bide Pharmaceutical Technology Co., Ltd. and the addition of certified core technicians
Bide Pharmaceutical: Explanation of the review opinions and disclosure of the supervisory board of Shanghai Bide Pharmaceutical Technology Co., Ltd. on the list of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan
Explanation of the review opinions and publicity of the board of supervisors of Shanghai Bide Pharmaceutical Technology Co., Ltd. on the list of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan
Announcement on the resignation of the company\'s core technical personnel and the addition of certified core technical personnel
Bide Pharmaceutical: 2025 First Extraordinary General Meeting of Shareholders Meeting Information
Bide Pharmaceuticals: Bide Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)
Bide Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)
Announcement of Resolutions of the 13th Meeting of the 2nd Board of Directors
Notice on Public Solicitation of Independent Directors\' Right to Delegate Voting
Announcement of Resolutions of the 10th Meeting of the 2nd Board of Supervisors
2024 Restricted Stock Incentive Plan (Draft) Summary Announcement
The Company\'s 2024 Restricted Stock Incentive Plan granted a list of incentive recipients for the first time
2024 Restricted Stock Incentive Plan Implementation Assessment Management Measures
Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Supervisory Board\'s Review Opinions on the Company\'s 2024 Restricted Stock Incentive Plan (Draft)
Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on the 2024 Restricted Stock Incentive Plan (Draft) of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Legal Opinion of Shanghai Junlan Law Firm on Bidet Pharmaceuticals 2024 Restricted Stock Incentive Plan (Draft)
Haitong Securities Co., Ltd. inspection opinion on the departure of the director, deputy general manager and core technical personnel of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement on the resignation of the company\'s director, deputy general manager and core technical personnel
Bide Pharmaceutical: Announcement on changing the signed certified public accountant
No Data
